Feb 24, 2026 04:06PM
Jan 21, 2026 04:15AM
Jan 7, 2026 06:32AM
Jan 6, 2026 04:08PM
Jan 6, 2026 01:57PM
Jan 6, 2026 09:18AM
Jan 6, 2026 06:58AM Alumis (ALMS) Halted, News Pending
Dec 18, 2025 09:57AM
Aug 14, 2025 07:39AM
Jul 25, 2025 06:40AM
Jul 14, 2025 04:05PM
Jun 10, 2025 06:08AM
May 29, 2025 07:56AM
May 21, 2025 09:11AM Alumis (ALMS) Completes Merger with ACELYRIN
May 13, 2025 01:00PM
May 13, 2025 01:00PM
May 1, 2025 01:31PM
Apr 22, 2025 06:59AM
Apr 21, 2025 06:36AM
Apr 4, 2025 04:36PM
Mar 26, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Alumis Inc (ALMS)
Mar 25, 2025 08:38AM
Mar 20, 2025 01:42PM
Mar 20, 2025 08:06AM
Mar 20, 2025 06:38AM
Mar 10, 2025 06:48AM
Mar 4, 2025 09:05AM
Feb 28, 2025 09:09AM Alumis (ALMS) Announces Late-Breaker Psoriasis Presentation of 52-week Phase 2 OLE Data for ESK-001
Feb 27, 2025 04:15PM
Feb 21, 2025 07:21AM
Feb 7, 2025 06:48AM
Feb 6, 2025 04:16PM
Feb 6, 2025 04:15PM
Jan 30, 2025 06:14AM
Jan 28, 2025 08:05AM Alumis (ALMS) Announces Leadership Changes
Jan 6, 2025 07:09AM
Dec 19, 2024 08:00AM
Nov 14, 2024 06:58AM
Oct 30, 2024 04:08PM
Oct 17, 2024 09:22AM
Sep 27, 2024 09:00AM
Jul 29, 2024 08:04AM Alumis (ALMS) Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
Jul 23, 2024 06:31AM
Jul 23, 2024 03:27AM
Jun 28, 2024 12:42PM
Jun 28, 2024 05:50AM
Jun 24, 2024 06:42AM
Jun 18, 2024 06:08AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All